Sigyn Therapeutics, Inc. announced the appointment of H. David Humes, MD to its Scientific Advisory Board. Dr. Humes is an internationally respected thought leader whose medical expertise is highly regarded across multiple industry segments.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.25 USD | +5.00% |
|
-.--% | +10.99% |
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+10.99% | 6.61M | |
-5.60% | 181B | |
-4.45% | 101B | |
-4.15% | 67.54B | |
-8.63% | 45.09B | |
+9.70% | 44.37B | |
+6.13% | 40.7B | |
+15.22% | 29.85B | |
+14.80% | 24.49B | |
-6.46% | 23.99B |
- Stock Market
- Equities
- SIGY Stock
- News Sigyn Therapeutics, Inc.
- Sigyn Therapeutics, Inc. Appoints H. David Humes, MD to Its Scientific Advisory Board